Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy

Dermatology

Volumn 209, Issue 3, 2004, Pages 243-245

  Isogai, Rieko ^a   Kawada, Akira ^a   Hashimoto, Keiko ^a   Aragane, Yoshinori ^a   Tezuka, Tadashi ^a   Maeda, Yasuhiro ^a   Kanamaru, Akihisa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epstein Barr virus; NK T cell lymphoma, nasal type; P glycoprotein; ProMACE CytaBOM

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; BLOOD CHEMISTRY; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; ENDOSCOPY; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SCINTIGRAPHY; SKIN LYMPHOMA; SKIN NODULE; SOUTHERN BLOTTING; T CELL LYMPHOMA; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS VIRULENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FACIAL NEOPLASMS; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, CUTANEOUS; MALE; METHOTREXATE; PREDNISONE; SKIN NEOPLASMS; VINCRISTINE;

EID: 5644244189     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079901     Document Type: Article

References (20)

1. Jaffe ES: Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996;87:1207-1210.
2. Tsang WY, Chan JK, Yip TT, Ng CS, Wong KF, Poon YF, Ma VW: In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphoma. Hum Pathol 1994;25:758-765.
3. Nakamura S, Suchi T, Koshikawa T, Kitoh K, Koike K, Komatsu H, Iida S, Kagami Y, Ogura M, Katoh E, Kurita S, Suzuki H, Kobashi Y, Yamabe H, Hirabayashi N, Ueda R, Takahashi T: Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-296.
4. Jaffe ES, Chan JKC, Su I-J, Frizzera G, Mori S, Feller AC, Ho FCS: Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol 1996;20:103-111.
5. Iwatsuki K, Ohtuka M, Harada H, Han G, Kaneko F: Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 1997;133:1081-1086.
6. Chan JKC: CD 56-positive putative natural killer (NK) cell lymphomas: Nasal, nasal-type, blastoid, and leukemic forms. Adv Anat Pathol 1997;4:163-172.
7. Chan JKC, Sin VC, Wong KF, Ng CS, Tsang YW, Chan CH, Cheung MMC, Lau WH: Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501-4513.
8. Nakamura S, Katoh E, Koshikawa T, Yatabe Y, Nagasaka T, Ishida H, Tokoro Y, Koike K, Kagami Y, Ogura M, Kojima M, Nara Y, Mizoguchi Y, Hara K, Kurita S, Seto M, Suchi T: Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol Int 1997;47:38-53.
9. Suzumiya J, Ohshima K, Takeshita M, Kanda M, Kawasaki C, Kimura N, Tamura K, Kikuchi M: Nasal lymphomas in Japan: A high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene. Leuk Lymphoma 1999;35:567-578.
10. Egashira M, Kawamata N, Sugimoto K, Kaneko T, Oshimi K: P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC 833. Blood 1999;93:599-606.
11. Yamamoto T, Iwasaki T, Watanabe N, Oshimi K, Naito M, Tsuruo T, Kobayashi Y: Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. Blood 1993;81:1342-1346.
12. Drénou B, Lamy T, Amiot L, Fardel O, Caulet-Maugendre S, Sasportes M, Diebold J, Le Prisé PY, Fauchet R: CD3-CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Blood 1997;89:2966-2974.
13. Lamy T, Drénou B, Fardel O, Amiot L, Grulois I, Le Prisé PY, Loughran TP, Fauchet R: Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes. Br J Haematol 1998;100:509-515.
14. Yu KH, Yu SCH, Teo PML, Chan ATC, Yeo W, Chow J: Nasal lymphoma: Results of local radiotherapy with or without chemotherapy. Head Neck 1997;19:251-259.
15. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, Hong WP, Park IY, Hahn JS, Roh JK, Kim BS: Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 2000;18:54-63.
16. Liang R, Todd D, Chan TK, Chiu E, Lie A, Kwong YL, Choy D, Ho FCS: Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995;13:666-670.
17. Cheung MMC, Chan JKC, Lau WH, Foo W, Chan PTM, Ng CS, Ngan RKC: Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70-77.
18. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
19. Raab-Traub N, Flynn K: The structure of termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-889.
20. Yamaguchi M, Kita K, Miwa H, Nishii K, Oka K, Ohno T, Shirakawa S, Fukumoto M: Frequent expression of P-glycoprotein/MDR1 by nasal Tcell lymphoma cells. Cancer 1995;76:2351-2356.